Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Mol Histol ; 35(1): 63-8, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15323350

RESUMO

In order to study the presence of sulphated glycoconjugates in the first mineralised layer juxtaposed to the root dentine (the hyaline layer), we have examined the early stages of molar root development by ultrastructural cytochemistry using Cuprolinic Blue combined with enzymatic pretreatment. Upper molars from 10 to 13 day-old Wistar rats were fixed in 2.5% glutaraldehyde containing 0.05% Cuprolinic Blue in 25 mM sodium acetate, pH 5.6, containing 0.3 M MgCl2. Some specimens were previously treated with heparitinase or chondroitinase ABC. Our results showed sulphated glycoconjugate--Cuprolinic Blue complexes that appeared as electron opaque ribbon-like deposits in the unmineralised hyaline layer. Few complexes were detected adjacent to the dentinal surface. These complexes were removed by heparitinase, indicating that they contained heparan sulphate chains. In contrast, the complexes found in unmineralised cementum and root dentine were removed by chondroitinase, indicating that they contained chondroitin or dermatan sulphate chains. The complexes decreased after the initiation of mineralisation of hyaline layer and root dentine and they were no longer present in stages of fully mineralisation. We conclude that the hyaline layer only contains sulphated glycoconjugates prior to mineralisation, and that they may play a role in the regulation of the mineralisation.


Assuntos
Glicoconjugados/análise , Dente Molar/crescimento & desenvolvimento , Animais , Calcificação Fisiológica/efeitos dos fármacos , Cementogênese/efeitos dos fármacos , Condroitina ABC Liase/farmacologia , Dentinogênese/efeitos dos fármacos , Glicoconjugados/química , Hialina/química , Hialina/metabolismo , Hialina/ultraestrutura , Indóis/análise , Indóis/química , Dente Molar/química , Dente Molar/ultraestrutura , Compostos Organometálicos/análise , Compostos Organometálicos/química , Polissacarídeo-Liases/farmacologia , Ratos , Ratos Wistar , Sulfatos/análise , Sulfatos/química
2.
Exp Eye Res ; 77(2): 157-65, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12873445

RESUMO

Retinal explants maintained in culture medium retain their histotypic structure and develop similarly to the in vivo condition. Extracellular matrix components, particularly the glycosaminoglycans which are not routinely present in dissociated cell cultures are involved in various cellular events. In this work we characterized and determined the localization of sulfated glycosaminoglycans in the extracellular matrix of rat retinal explants at various stages of normal postnatal development and tested whether disruption of the tissue glycosaminoglycan composition may impose either trophic or toxic effects upon distinct retinal cell populations. Our data show that chondroitin sulfate and heparan sulfate glycosaminoglycan chains are synthesized in different proportions during postnatal retinal development. A peak of synthesis of chondroitin sulfates is evident at around P14. Immunohistochemistry showed chondroitin 6-sulfate in the plexiform layers during the earlier stages while later, intense immunoreactivity was found in the outer retina. Heparan sulfate was found in the neuroblastic layer (NBL) at P1, in both nuclear layers from P5 onwards and in the ganglion cell layer (GCL) at all stages. In contrast to chondroitin 6-sulfate, immunoreactivity to heparan sulfate was absent from the outer retina at both P14 and P21. Treatment with heparitinase modulated the rates of cell death in both the GCL and the NBL in P1 retinal explants. Taken together our data show that among the major sulfated glycosaminoglycans, the developing rat retina synthesizes only heparan sulfate and chondroitin sulfates in a spatiotemporally regulated manner, with a peak of chondroitin sulfates at P14, possibly related to photoreceptor differentiation. In addition, our data suggest a role for heparan sulfate as a modulator of sensitivity to cell death in the retina.


Assuntos
Glicosaminoglicanos/metabolismo , Retina/crescimento & desenvolvimento , Animais , Morte Celular/efeitos dos fármacos , Condroitina ABC Liase/farmacologia , Imuno-Histoquímica , Polissacarídeo-Liases/farmacologia , Ratos , Retina/metabolismo , Distribuição Tecidual
3.
Braz J Med Biol Res ; 36(8): 993-1002, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12886453

RESUMO

Proteoglycans are abundant in the developing brain and there is much circumstantial evidence for their roles in directional neuronal movements such as cell body migration and axonal growth. We have developed an in vitro model of astrocyte cultures of the lateral and medial sectors of the embryonic mouse midbrain, that differ in their ability to support neuritic growth of young midbrain neurons, and we have searched for the role of interactive proteins and proteoglycans in this model. Neurite production in co-cultures reveals that, irrespective of the previous location of neurons in the midbrain, medial astrocytes exert an inhibitory or nonpermissive effect on neuritic growth that is correlated to a higher content of both heparan and chondroitin sulfates (HS and CS). Treatment of astrocytes with chondroitinase ABC revealed a growth-promoting effect of CS on lateral glia but treatment with exogenous CS-4 indicated a U-shaped dose-response curve for CS. In contrast, the growth-inhibitory action of medial astrocytes was reversed by exogenous CS-4. Treatment of astrocytes with heparitinase indicated that the growth-inhibitory action of medial astrocytes may depend heavily on HS by an as yet unknown mechanism. The results are discussed in terms of available knowledge on the binding of HS proteoglycans to interactive proteins, with emphasis on the importance of unraveling the physiological functions of glial glycoconjugates for a better understanding of neuron-glial interactions.


Assuntos
Axônios/fisiologia , Sulfatos de Condroitina/fisiologia , Heparitina Sulfato/fisiologia , Mesencéfalo/embriologia , Neurônios/fisiologia , Agrecanas , Animais , Astrócitos/efeitos dos fármacos , Astrócitos/fisiologia , Divisão Celular/fisiologia , Movimento Celular , Células Cultivadas , Proteoglicanas de Heparan Sulfato/fisiologia , Mesencéfalo/citologia , Camundongos , Neuroglia/fisiologia , Polissacarídeo-Liases/farmacologia , Proteoglicanas/fisiologia
4.
Biochem Pharmacol ; 63(1): 65-72, 2002 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-11754875

RESUMO

The purpose of this study was to examine the ability of type I- (porcine pancreas and Naja mocambique mocambique venom), type II- (bothropstoxin-I, bothropstoxin-II, and piratoxin-I), and type III- (Apis mellifera venom) secretory phospholipases A2 (sPLA2s) to induce human neutrophil chemotaxis, and the role of the cell surface proteoglycans, leukotriene B4 (LTB4), and platelet-activating factor (PAF), in mediating this migration. The neutrophil chemotaxis assays were performed by using a 48-well microchemotaxis chamber. Piratoxin-I, bothropstoxin-I, N. m. mocambique venom PLA2 (10-1000 microg/mL each), bothropstoxin-II (30-1000 microg/mL), porcine pancreas PLA2 (0.3-30 microg/mL), and A. mellifera venom PLA2 (30-300 microg/mL) caused concentration-dependent neutrophil chemotaxis. Heparin (10-300 U/mL) concentration-dependently inhibited the neutrophil migration induced by piratoxin-I, bothropstoxin-II, and N. m. mocambique and A. mellifera venom PLA2s (100 microg/mL each), but failed to affect the migration induced by porcine pancreas PLA2. Heparan sulfate (300 and 1000 microg/mL) inhibited neutrophil migration induced by piratoxin-I, whereas dermatan sulfate and chondroitin sulfate (30-1000 microg/mL each) had no effect. Heparitinase I and heparinase (300 mU/mL each) inhibited by 41.5 and 47%, respectively, piratoxin-I-induced chemotaxis, whereas heparitinase II and chondroitinase AC failed to affect the chemotaxis. The PAF receptor antagonist WEB 2086 (3-[4-(2-chlorophenyl)-9-methyl-6H-thienol-[3,2-f] -triazolo-[4,3-a] -diazepine-2-yl]-1-(4-morpholynil)-1-propionate) (0.1-10 microM) and the LTB4 synthesis inhibitor AA-861 [2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone] (0.1-10 microM) significantly inhibited the piratoxin-I-induced chemotaxis. Piratoxin-I (30-300 microg/mL) caused a concentration-dependent release of LTB4. Our results suggest that neutrophil migration in response to sPLA2s is independent of PLA activity, and involves an interaction of sPLA2s with cell surface heparin/heparan binding sites triggering the release of LTB4 and PAF.


Assuntos
Movimento Celular/fisiologia , Glicosaminoglicanos/fisiologia , Neutrófilos/enzimologia , Fosfolipases A/fisiologia , Azepinas/farmacologia , Benzoquinonas/farmacologia , Movimento Celular/efeitos dos fármacos , Quimiotaxia/fisiologia , Condroitina Liases/farmacologia , Flavobacterium/enzimologia , Heparina/farmacologia , Heparina Liase/farmacologia , Humanos , Técnicas In Vitro , Leucotrieno B4/metabolismo , Inibidores de Lipoxigenase/farmacologia , Neutrófilos/efeitos dos fármacos , Neutrófilos/fisiologia , Fosfolipases A2 , Inibidores da Agregação Plaquetária/farmacologia , Polissacarídeo-Liases/farmacologia , Triazóis/farmacologia
5.
J Cell Physiol ; 178(1): 51-62, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9886490

RESUMO

Epithelial cells are important components of the thymus microenvironment and are involved in thymocyte differentiation. The production and secretion of sulfated glycosaminoglycans by these cells grown in culture were investigated using labeling with radioactive 35S-Na2SO4 and 3H-glucosamine. The major glycosaminoglycans synthesized by these cells are heparan sulfate and hyaluronic acid. The structure of the heparan sulfate was investigated by the pattern of degradation products formed by deaminative cleavage with nitrous acid. The ratio 35S-sulfate/ H-glucosamine is high in the segments of the heparan sulfate released during the deaminative cleavage with nitrous acid but low in the resistant portion of the molecule. Thus, the heparan sulfate synthesized by the thymic epithelial cells contains a highly sulfated region. Digestion with heparitinase reveals that this highly sulfated region is a heparin-like segment of the molecule. The heparan sulfate is rapidly incorporated into the cell surface but its secretion to the extracellular medium requires a longer incubation period. Finally, heparin was used to mimic the possible effect of this heparan sulfate with a highly sulfated region, as ascertained by its ability to modulate thymocyte adhesion to thymic epithelial cells. Since heparin actually enhanced thymocyte adhesion, it is suggested that the heparan sulfate described herein, secreted by the thymic epithelium, may play a role upon intrathymic heterotypic cellular interactions.


Assuntos
Células Epiteliais/metabolismo , Heparitina Sulfato/biossíntese , Heparitina Sulfato/metabolismo , Enxofre/metabolismo , Timo/citologia , Animais , Fracionamento Celular , Linhagem Celular , Sulfatos de Condroitina/biossíntese , Sulfatos de Condroitina/metabolismo , Ensaios Enzimáticos Clínicos , Dissacarídeos/metabolismo , Células Epiteliais/citologia , Feminino , Glicosaminoglicanos/metabolismo , Ácido Hialurônico/biossíntese , Ácido Hialurônico/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Oligossacarídeos/metabolismo , Polissacarídeo-Liases/farmacologia , Radioisótopos de Enxofre , Fatores de Tempo , Trítio
6.
J Cell Biochem ; 65(2): 145-58, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9136074

RESUMO

The interaction between the Alzheimer amyloid precursor protein (APP) and an intact extracellular matrix (ECM), matrigel, obtained from Engelbreth-Holm-Swarm tumors was evaluated. Based on quantitative analyses of the binding data obtained from solid phase binding assays, two binding sites on the ECM were identified for [125I]-APP (with apparent Kd1 of 1.0 x 10(-11) M and Kd2 of 1.6 x 10(-9) M respectively). Over 70% of [125I]-APP was displaced by heparin and N-desulfated heparin but not by chondroitin sulfate. Pretreatment of matrigel with heparitinase decreased the binding of [125I]-APP by 80%. beta-amyloid peptides (residues 1-40, 1-28, and 1-16) containing a heparin binding domain also displaced 80% of bound [125I]-APP, which was totally displaced by intact APP. The binding of [125I]-APP to matrigel increased by 210% with a decrease in the pH. These observations suggest that [125I]-APP interacts mainly with heparan sulfate proteoglycan present in the ECM. The binding of [125I]-APP to individual ECM components was also analyzed. [125I]-APP was found to bind laminin and collagen type IV but not fibronectin. However, when these ECM constituents were combined, the extent of APP-binding decreased significantly, to levels comparable to those obtained with intact matrigel, suggesting that multiple interactions may occur between ECM constituents and [125I]-APP. The results are discussed in terms of APP function and amyloidogenesis.


Assuntos
Doença de Alzheimer/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Matriz Extracelular/metabolismo , Heparitina Sulfato/metabolismo , Proteoglicanas/metabolismo , Sítios de Ligação , Ligação Competitiva , Colágeno/metabolismo , Combinação de Medicamentos , Fibronectinas/metabolismo , Proteoglicanas de Heparan Sulfato , Humanos , Concentração de Íons de Hidrogênio , Radioisótopos do Iodo , Cinética , Laminina/metabolismo , Polissacarídeo-Liases/farmacologia
7.
J Lipid Res ; 37(9): 1987-2000, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8895065

RESUMO

Lipoprotein lipase (LPL) induced, in a dose-dependent fashion, a 2-fold and 11-fold increase in the proliferative response of peripheral blood lymphocytes (PBL) at 48 and 72 h, respectively; a 4- and 12-fold increase in natural killer (NK) cells, respectively; and a maximal 3-fold induction in interleukin-2 (IL-2)-treated NK cells at 72 h. T lymphocytes did not proliferate independently of the concentration of LPL used. LPL decreased the proliferative response of K562 and U937 cell lines. The effect on NK cells could be blocked by anti-LPL if it was added before LPL binding to the cell membrane. Contrary to its effects on NK proliferative response, LPL inhibited spontaneous cytotoxicity and lymphokine-activated killer activity (LAK). The effect was dose-dependent, target-dependent (U937 was more sensitive than K562 in LAK assays), but not LPL-binding time-dependent. Treatment of NK cells with heparinase overcame the inhibitory effect of LPL in spontaneous cytotoxicity. LPL binding to cell membranes, as assessed by flow cytometry, was as follows: K562 cells > monocytes > NK cells > LAK cells > U937 cells, absent in T lymphocytes and partially sensible to heparinase and IL-2 treatments. Protein kinase C translocation was observed upon treatment of NK cells with LPL. Three proteins in NK cell membrane (76, 57.2, and 27.2 kD), two in the cytosol (57.2 and 27.2 kD), and only one in ANA-1 cell membrane (76 kD) were precipitated with LPL-Sepharose. LPL receptors seem to be responsible for the proliferative and cytotoxic response observed in LPL-stimulated NK cells.


Assuntos
Citotoxicidade Imunológica/efeitos dos fármacos , Células Matadoras Naturais/efeitos dos fármacos , Lipase Lipoproteica/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Receptores de Superfície Celular/metabolismo , Membrana Celular/metabolismo , Relação Dose-Resposta a Droga , Heparina Liase , Humanos , Interleucina-2/farmacologia , Células Matadoras Ativadas por Linfocina/efeitos dos fármacos , Lipase Lipoproteica/metabolismo , Polissacarídeo-Liases/farmacologia , Ligação Proteica , Proteína Quinase C
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA